0001803599-21-000194.txt : 20211103 0001803599-21-000194.hdr.sgml : 20211103 20211103181116 ACCESSION NUMBER: 0001803599-21-000194 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211101 FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POLK DENNIS CENTRAL INDEX KEY: 0001270710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39494 FILM NUMBER: 211376988 MAIL ADDRESS: STREET 1: 44201 NOBEL DRIVE CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Concentrix Corp CENTRAL INDEX KEY: 0001803599 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 271605762 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 BUSINESS ADDRESS: STREET 1: 44111 NOBEL DRIVE CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 1-510-565-3178 MAIL ADDRESS: STREET 1: 44111 NOBEL DRIVE CITY: FREMONT STATE: CA ZIP: 94538 4 1 wf-form4_163597746107272.xml FORM 4 X0306 4 2021-11-01 0 0001803599 Concentrix Corp CNXC 0001270710 POLK DENNIS 44201 NOBEL DRIVE FREMONT CA 94538 1 0 0 0 Common Stock 2021-11-01 4 M 0 5000 37.94 A 32532 D Common Stock 2021-11-01 4 S 0 200 173.84 D 32332 D Common Stock 2021-11-01 4 S 0 400 175.09 D 31932 D Common Stock 2021-11-01 4 S 0 700 175.697 D 31232 D Common Stock 2021-11-01 4 S 0 2222 177.786 D 29010 D Common Stock 2021-11-01 4 S 0 183 178.254 D 28827 D Common Stock 2021-11-01 4 S 0 1295 179.663 D 27532 D Employee Stock Option (Right to Buy) 37.94 2021-11-01 4 M 0 5000 0 D 2028-10-11 Common Stock 5000.0 57101 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2021. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.41 to $174.29, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.56 to $175.52, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.56 to $175.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.22 to $178.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.24 to $178.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.37 to $180.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter. /s/ Andrew A. Farwig, Attorney-in-Fact 2021-11-03